We are live on !
Find out more
Parallel Advisors Portfolio holdings
AUM
$7.42B
Turnover
9.77%
1-Year Est. Return
27.68%
Parallel Advisors is a wealth manager that puts financial planning first, with in-house tax and trust services and a family office. It was founded in 2006 and is led by chief executive Jerry Rendic, with Prism Topco as its principal owner. The firm sells no products of its own, so its advisors can pick from outside funds, including low-cost index funds. It works with families and institutions.
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+27.68%
3 Year Est. Return
+122.34%
5 Year Est. Return
+126.9%
10 Year Est. Return
+398.12%
AUM
$7.42B
AUM Growth
+$855M
(+13%)
Cap. Flow
+$618M
Cap. Flow % of AUM
Cap. Flow %
8.34%
Top 10 Holdings %
Top 10 Hldgs %
37.36%
Holding
4,186
New
256
Increased
1,963
Reduced
1,120
Closed
153
Avg Time Held
Equity + Options
4.9
years
Top 10 Avg Time Held
Equity + Options
4
years
Top 20 Avg Time Held
Equity + Options
4.7
years
Avg Time Held Equity only
4.9
years
Top 10 Avg Time Held Equity only
4
years
Top 20 Avg Time Held Equity only
4.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$50.8M |
| 2 |
iShares International Country Rotation Active ETF
CORO
|
+$41.6M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$35.7M |
| 4 |
PIMCO Multi Sector Bond Active ETF
PYLD
|
+$32.5M |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust WCM International Equity ETF
WCMI
|
+$14.1M |
| 2 |
Avantis International Equity ETF
AVDE
|
+$7.51M |
| 3 |
Corcept Therapeutics
CORT
|
+$6.41M |
| 4 |
Crown Castle
CCI
|
+$6.2M |
| 5 |
VictoryShares Free Cash Flow ETF
VFLO
|
+$4.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.31% |
| 2 | Technology | 17.75% |
| 3 | Healthcare | 9.55% |
| 4 | Financials | 5.39% |
| 5 | Communication Services | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3701
Community Bank
CBU
$3.46B
| $1.25K | ﹤0.01% |
21
| – | – |
2026 Q1
2 quarters
|
|
3702
State Street SPDR Portfolio TIPS Index ETF
SPIP
$1.06B
| $1.24K | ﹤0.01% |
51
-107
| -68% | -$2.68K |
2024 Q3
8 quarters
|
|
3703
Keel Infrastructure Corp
KEEL
$1.32B
| $1.24K | ﹤0.01% |
350
| – | – |
2023 Q4
11 quarters
|
|
3704
Harrow
HROW
$1.08B
| $1.23K | ﹤0.01% |
40
| – | – |
2025 Q2
5 quarters
|
|
3705
Lumexa Imaging Holdings
LMRI
$1.24B
| $1.23K | ﹤0.01% |
+120
| New | +$1.36K |
2026 Q3
0 quarters
|
|
3706
Brandywine Realty Trust
BDN
$539M
| $1.23K | ﹤0.01% |
439
-403
| -48% | -$1.23K |
2025 Q4
3 quarters
|
|
3707
Covenant Logistics
CVLG
$858M
| $1.23K | ﹤0.01% |
38
-9
| -19% | -$344 |
2022 Q3
16 quarters
|
|
3708
IperionX
IPX
$542M
| $1.23K | ﹤0.01% |
73
-1,571
| -96% | -$35.1K |
2026 Q1
2 quarters
|
|
3709
Community Health Systems
CYH
$329M
| $1.22K | ﹤0.01% |
+427
| New | +$1.3K |
2026 Q3
0 quarters
|
|
3710
Arvinas
ARVN
$486M
| $1.21K | ﹤0.01% |
157
| – | – |
2023 Q3
12 quarters
|
|
3711
Skyward Specialty Insurance
SKWD
$2.76B
| $1.21K | ﹤0.01% |
23
| – | – |
2026 Q2
1 quarter
|
|
3712
MetroCity Bankshares
MCBS
$1.05B
| $1.2K | ﹤0.01% |
35
| – | – |
2025 Q2
5 quarters
|
|
3713
Abeona Therapeutics
ABEO
$241M
| $1.19K | ﹤0.01% |
227
-173
| -43% | -$1.07K |
2022 Q1
18 quarters
|
|
3714
Absci
ABSI
$1.75B
| $1.18K | ﹤0.01% |
110
-14
| -11% | -$128 |
2026 Q2
1 quarter
|
|
3715
vTv Therapeutics
VTVT
$94.7M
| $1.17K | ﹤0.01% |
38
| – | – |
2020 Q2
25 quarters
|
|
3716
NextDecade
NEXT
$1.69B
| $1.16K | ﹤0.01% |
182
-27
| -13% | -$194 |
2022 Q4
15 quarters
|
|
3717
Acadia Pharmaceuticals
ACAD
$3.69B
| $1.15K | ﹤0.01% |
57
-100
| -64% | -$2.68K |
2024 Q3
8 quarters
|
|
3718
Neuropace
NPCE
$469M
| $1.13K | ﹤0.01% |
+82
| New | +$1.22K |
2026 Q3
0 quarters
|
|
3719
Oric Pharmaceuticals
ORIC
$965M
| $1.12K | ﹤0.01% |
83
| – | – |
2025 Q2
5 quarters
|
|
3720
Quanex
NX
$1.03B
| $1.11K | ﹤0.01% |
59
-37
| -39% | -$721 |
2024 Q4
7 quarters
|
|
3721
Hanmi Financial
HAFC
$996M
| $1.11K | ﹤0.01% |
+36
| New | +$1.15K |
2026 Q3
0 quarters
|
|
3722
Ultragenyx Pharmaceutical
RARE
$1.72B
| $1.11K | ﹤0.01% |
74
-1,634
| -96% | -$39.2K |
2021 Q3
20 quarters
|
|
3723
Phibro Animal Health
PAHC
$1.6B
| $1.11K | ﹤0.01% |
31
| – | – |
2026 Q2
1 quarter
|
|
3724
Bankwell Financial Group
BWFG
$584M
| $1.1K | ﹤0.01% |
17
| – | – |
2026 Q1
2 quarters
|
|
3725
Telix Pharmaceuticals
TLX
$3.27B
| $1.1K | ﹤0.01% |
100
| – | – |
2025 Q4
3 quarters
|
|
Similar funds
Parallel Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, Parallel Advisors held 4,186 positions worth $7.42B, up 13% from $6.56B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors deployed $618M of net new capital in Q3 2026, opening 256 new positions and adding to 1,963 existing holdings. Its largest new stake was Fidelity International High Dividend ETF: 314,039 shares worth $8.73M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, up from 49% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was First Trust WCM International Equity ETF, an estimated $14.1M trimmed.
- Parallel Advisors's largest Q3 2026 buy was Fidelity International High Dividend ETF: 314,039 shares worth $8.73M.
- Parallel Advisors added most to Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF in Q3 2026, an estimated $50.8M increase.
- Parallel Advisors's biggest Q3 2026 reduction was First Trust WCM International Equity ETF, cutting an estimated $14.1M.
- Parallel Advisors fully exited Electronic Arts in Q3 2026, selling an estimated $1.54M.
- Parallel Advisors's ten largest holdings make up 37% of its $7.42B portfolio in Q3 2026.
- Parallel Advisors opened 256 new positions and closed 153 in Q3 2026.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $7.42B.
Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.